ATE341547T1 - Difurylglykolsäuretropenolester als anticholinergika - Google Patents

Difurylglykolsäuretropenolester als anticholinergika

Info

Publication number
ATE341547T1
ATE341547T1 AT03706609T AT03706609T ATE341547T1 AT E341547 T1 ATE341547 T1 AT E341547T1 AT 03706609 T AT03706609 T AT 03706609T AT 03706609 T AT03706609 T AT 03706609T AT E341547 T1 ATE341547 T1 AT E341547T1
Authority
AT
Austria
Prior art keywords
formula
quaternized
new
acid
optionally
Prior art date
Application number
AT03706609T
Other languages
German (de)
English (en)
Inventor
Gerd Morschhaeuser
Michael P Pieper
Georg Speck
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE341547T1 publication Critical patent/ATE341547T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03706609T 2002-03-16 2003-03-10 Difurylglykolsäuretropenolester als anticholinergika ATE341547T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10211700A DE10211700A1 (de) 2002-03-16 2002-03-16 Neue Difurylglykolsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE341547T1 true ATE341547T1 (de) 2006-10-15

Family

ID=27771378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706609T ATE341547T1 (de) 2002-03-16 2003-03-10 Difurylglykolsäuretropenolester als anticholinergika

Country Status (8)

Country Link
EP (1) EP1487831B1 (https=)
JP (1) JP2005520832A (https=)
AT (1) ATE341547T1 (https=)
AU (1) AU2003208703A1 (https=)
CA (1) CA2476746A1 (https=)
DE (2) DE10211700A1 (https=)
ES (1) ES2272947T3 (https=)
WO (1) WO2003078428A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037280A1 (en) * 2003-10-14 2005-04-28 Glaxo Group Limited Muscarinic acetycholine receptor antagonists
US20080027094A1 (en) * 2004-08-30 2008-01-31 Ono Pharmaceutical Co., Ltd. Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
WO2003078428A1 (de) 2003-09-25
ES2272947T3 (es) 2007-05-01
DE10211700A1 (de) 2003-09-25
JP2005520832A (ja) 2005-07-14
AU2003208703A1 (en) 2003-09-29
CA2476746A1 (en) 2003-09-25
EP1487831B1 (de) 2006-10-04
DE50305263D1 (de) 2006-11-16
EP1487831A1 (de) 2004-12-22

Similar Documents

Publication Publication Date Title
CO5540380A2 (es) Medicamentos inhalativos que contienen un nuevo anticolinergico en combinacion con corticosteroides y betamimeticos
HRP20030276B1 (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AR035589A1 (es) Esteres de acido difenilmetilcarboxilico con efecto anticolinergico, un procedimiento para su preparacion, el uso de los mismos para la preparacion de un medicamento y los preparados farmaceuticos que los contienen
ATE86110T1 (de) Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.
EA200600497A1 (ru) Композиция для аэрозольной ингаляции, содержащая антихолинергическое средство
AR082015A1 (es) Derivados de metoxifenilo heterociclicamente sustituidos con un grupo oxo, procedimientos para su preparacion y uso de los mismos como medicamentos
NO2013002I2 (no) Aklidiniumsalt med et farmaøytisk akseptabelt anion av en mono-eller polyvalent syre, spesielt aklidiniumbromid
ATE228132T1 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
CY1108776T1 (el) Σκευασμα αερολυματος για εισπνοη που περιεχει αντιχολινεργικο
CA2471578A1 (en) Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
CO6170341A2 (es) Formulacion de aerosol que contiene derivados de benzoxazin-3onas
PE20050250A1 (es) Antagonistas de los receptores muscarinicos de la acetilcolina
ATE341547T1 (de) Difurylglykolsäuretropenolester als anticholinergika
MY137045A (en) Medicaments comprising steroids and a novel anticholinergic
AR044570A1 (es) 3-aminopirrolidinas como inhibidores de la captacion de monoaminas
AU2003222290A1 (en) Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
ZA200409676B (en) Novel drug compositions based on novel anticholinergics and inhibitors of EGFR-kinase
AR062476A1 (es) Beta - agonistas enentiomericamente puros, procedimientos para su preparacion y su uso como medicamentos
ES2087474T3 (es) Derivados de aril-3 oxazolidinona, procedimiento de preparacion y aplicacion terapeutica de los mismos.
SE0104333D0 (sv) Therapeutic agents
AR059126A1 (es) Uso de sales de tiotropio en el tratamiento del asma persistente moderada
CN219293021U (zh) 一种双头激光打标机
CN223378026U (zh) 一种电抗器用全自动高压线圈绕线机
TW200744606A (en) Use of tiotropium salts in the treatment of severe persistent asthma
CO5251442A1 (es) Uso de compuestos de 4-amino-1-fenilbutano-2-ol sustituidos en forma de sus racematos, enantiomeros diastereomeros o bases o sales correspondientes con acidos fisiologicamente tolerables como reguladores para el sistema nociceptina/ orfanina fq ligan